Cohort1: ALN-TTR01_dose level 1
|
Administration route |
intravenous injection |
Dosage |
ALN-TTR01, 0.01 mg/kg |
Pts |
3 |
Age |
Adult, Older_Adult |
References |
PMID:
23984729
|
|
Cohort2: ALN-TTR01_dose level 2
|
Administration route |
intravenous injection |
Dosage |
ALN-TTR01, 0.03 mg/kg |
Pts |
3 |
Age |
Adult, Older_Adult |
References |
PMID:
23984729
|
|
Cohort3: ALN-TTR01_dose level 3
|
Administration route |
intravenous injection |
Dosage |
ALN-TTR01, 0.1 mg/kg |
Pts |
3 |
Age |
Adult, Older_Adult |
References |
PMID:
23984729
|
|
Cohort4: ALN-TTR01_dose level 4
|
Administration route |
intravenous injection |
Dosage |
ALN-TTR01, 0.2 mg/kg |
Pts |
3 |
Age |
Adult, Older_Adult |
References |
PMID:
23984729
|
|
Cohort5: ALN-TTR01_dose level 5
|
Administration route |
intravenous injection |
Dosage |
ALN-TTR01, 0.4 mg/kg |
Pts |
3 |
Age |
Adult, Older_Adult |
References |
PMID:
23984729
|
|
Cohort6: ALN-TTR01_dose level 6
|
Administration route |
intravenous injection |
Dosage |
ALN-TTR01, 0.7 mg/kg |
Pts |
3 |
Age |
Adult, Older_Adult |
References |
PMID:
23984729
|
|
Cohort7: ALN-TTR01_dose level 7
|
Administration route |
intravenous injection |
Dosage |
ALN-TTR01, 1.0 mg/kg |
Pts |
6 |
Age |
Adult, Older_Adult |
References |
PMID:
23984729
|
|
Cohort8: Sterile Normal Saline
|
Administration route |
intravenous injection |
Pts |
8 |
Age |
Adult, Older_Adult |
References |
PMID:
23984729
|
|